Literature DB >> 20100764

Burden of influenza-related hospitalizations among children with sickle cell disease.

David G Bundy1, John J Strouse, James F Casella, Marlene R Miller.   

Abstract

OBJECTIVE: Children with sickle cell disease (SCD) are considered to be at high risk for complications from influenza infection despite minimal published data that characterize the burden of influenza in this population. Our objectives were to (1) estimate the rate of influenza-related hospitalizations (IRHs) among children with SCD, (2) compare this rate with rates of children with cystic fibrosis (CF) and children with neither SCD nor CF, and (3) explore mechanisms that underlie these potentially preventable hospitalizations.
METHODS: We analyzed hospitalizations from 4 states (California, Florida, Maryland, and New York) across 2 influenza seasons (2003-2004 and 2004-2005) from the Healthcare Cost and Utilization Project State Inpatient Databases. We included hospitalizations with a discharge diagnosis code for influenza in a child <18 years of age. We used census data and disease prevalence estimates to calculate denominators and compare rates of IRH among children with SCD, CF, and neither disease.
RESULTS: There were 7896 pediatric IRHs during the 2 influenza seasons. Of these, 159 (2.0%) included a co-occurring diagnosis of SCD. Annual rates of IRHs were 112 and 2.0 per 10 000 children with and without SCD, respectively, across both seasons. Children with SCD were hospitalized with influenza at 56 times (95% confidence interval: 48-65) the rate of children without SCD. Children with SCD had approximately double the risk of IRH compared with children with CF (risk ratio: 2.1 [95% confidence interval: 1.5-2.9]). IRHs among children with SCD were not longer, more costly, or more severe than IRHs among children without SCD; they were also rarely nosocomial and co-occurred with a diagnosis of asthma in 14% of cases.
CONCLUSIONS: IRHs are substantially more common among children with SCD than among those without the disease, which supports the potential importance of vigorous influenza vaccination efforts that target children with SCD.

Entities:  

Mesh:

Year:  2010        PMID: 20100764      PMCID: PMC3283164          DOI: 10.1542/peds.2009-1465

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  42 in total

1.  Update: Influenza activity--United States and worldwide, 2004-05 season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-07-01       Impact factor: 17.586

2.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

Review 3.  Vaccines for preventing influenza in people with cystic fibrosis.

Authors:  A Tan; P Bhalla; R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2000

4.  Influenza-associated deaths among children in the United States, 2003-2004.

Authors:  Niranjan Bhat; Jennifer G Wright; Karen R Broder; Erin L Murray; Michael E Greenberg; Maleeka J Glover; Anna M Likos; Drew L Posey; Alexander Klimov; Stephen E Lindstrom; Amanda Balish; Marie-jo Medina; Teresa R Wallis; Jeannette Guarner; Christopher D Paddock; Wun-Ju Shieh; Sherif R Zaki; James J Sejvar; David K Shay; Scott A Harper; Nancy J Cox; Keiji Fukuda; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

Review 5.  Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

Authors:  Scott D Grosse; Coleen A Boyle; Jeffrey R Botkin; Anne Marie Comeau; Martin Kharrazi; Margaret Rosenfeld; Benjamin S Wilfond
Journal:  MMWR Recomm Rep       Date:  2004-10-15

6.  Influenza burden for children with asthma.

Authors:  E Kathryn Miller; Marie R Griffin; Kathryn M Edwards; Geoffrey A Weinberg; Peter G Szilagyi; Mary A Staat; Marika K Iwane; Yuwei Zhu; Caroline B Hall; Gerry Fairbrother; Ranee Seither; Dean Erdman; Pengjun Lu; Katherine A Poehling
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

7.  Identification and recall of children with chronic medical conditions for influenza vaccination.

Authors:  Matthew F Daley; Jennifer Barrow; Kellyn Pearson; Lori A Crane; Dexiang Gao; John M Stevenson; Stephen Berman; Allison Kempe
Journal:  Pediatrics       Date:  2004-01       Impact factor: 7.124

8.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

Authors:  Anthony E Fiore; David K Shay; Penina Haber; John K Iskander; Timothy M Uyeki; Gina Mootrey; Joseph S Bresee; Nancy J Cox
Journal:  MMWR Recomm Rep       Date:  2007-07-13

9.  High influenza vaccination coverage in children with high-risk conditions during a vaccine shortage.

Authors:  Mandy A Allison; Matthew F Daley; Jennifer Barrow; Lori A Crane; Brenda L Beaty; Norma Allred; Allison Kempe
Journal:  Arch Pediatr Adolesc Med       Date:  2009-05

Review 10.  Patient reminder and patient recall systems to improve immunization rates.

Authors:  Julie C Jacobson Vann; Peter Szilagyi
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20
View more
  35 in total

1.  The impact of the 2009 H1N1 influenza pandemic on pediatric patients with sickle cell disease.

Authors:  Alex George; Jennifer Benton; Jesse Pratt; Mi-Ok Kim; Karen A Kalinyak; Theodosia A Kalfa; Clinton H Joiner
Journal:  Pediatr Blood Cancer       Date:  2011-02-25       Impact factor: 3.167

Review 2.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

3.  Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease.

Authors:  John J Strouse; Megan E Reller; David G Bundy; Martha Amoako; Maria Cancio; Rachel N Han; Alexandra Valsamakis; James F Casella
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

4.  Association of care in a medical home and health care utilization among children with sickle cell disease.

Authors:  Jean L Raphael; Tiffany L Rattler; Marc A Kowalkowski; David C Brousseau; Brigitta U Mueller; Thomas P Giordano
Journal:  J Natl Med Assoc       Date:  2013       Impact factor: 1.798

5.  Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children.

Authors:  Caroline B Long; Irene Ramos; Deepa Rastogi; Deepa Manwani; Ginger Janow; Marcela Del Rio; Marguerite Mayers; Betsy C Herold; Ana Fernandez-Sesma; Rebecca Pellett Madan
Journal:  J Pediatr       Date:  2011-08-15       Impact factor: 4.406

6.  Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic.

Authors:  Amy E Sobota; Patricia L Kavanagh; William G Adams; Elizabeth McClure; Delmaude Farrell; Philippa G Sprinz
Journal:  Pediatr Blood Cancer       Date:  2014-12-24       Impact factor: 3.167

Review 7.  Sickle cell disease in children.

Authors:  Emily Riehm Meier; Jeffery L Miller
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

8.  Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017.

Authors:  Carol M Kao; Kristina Lai; John M McAteer; Mohnd Elmontser; Elizabeth M Quincer; Marianne E M Yee; Ashley Tippet; Robert C Jerris; Peter A Lane; Evan J Anderson; Nitya Bakshi; Inci Yildirim
Journal:  Pediatr Blood Cancer       Date:  2020-05-29       Impact factor: 3.167

9.  Preventive Care Delivery to Young Children With Sickle Cell Disease.

Authors:  David G Bundy; John Muschelli; Gwendolyn D Clemens; John J Strouse; Richard E Thompson; James F Casella; Marlene R Miller
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

Review 10.  Travelers with sickle cell disease.

Authors:  Shaina M Willen; Courtney D Thornburg; Paul M Lantos
Journal:  J Travel Med       Date:  2014-06-19       Impact factor: 8.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.